Processa Pharmaceuticals, Inc. Capital Expenditures
Processa Pharmaceuticals, Inc. (PCSA) reported Capital Expenditures of $3.24 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-03-20
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-06-30 was $0.00.
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-03-31 was $882.00.
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $3.24K, a 16.86% increase from fiscal 2023.
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $2.78K.
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $20.62K, a 13.26% decline from fiscal 2016.
- Processa Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $23.77K, a 1599.43% increase from fiscal 2015.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed | Payments to Acquire Property, Plant, and Equipment 27 month | Payments to Acquire Property, Plant, and Equipment 30 month | Payments to Acquire Property, Plant, and Equipment 33 month | Payments to Acquire Property, Plant, and Equipment 36 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $3.24K 10-K · filed 2025-03-20 | ||||||||
| 2024-09-30 | $3.24K 10-Q · filed 2024-10-30 | |||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $2.78K 10-K · filed 2025-03-20 | ||||||||
| 2023-09-30 | $2.78K 10-Q · filed 2024-10-30 | |||||||||
| 2017-12-31 | $20.62K 10-K/A · filed 2019-04-08 | |||||||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $882.00 10-Q · filed 2018-08-14 | ||||||||
| 2017-03-31 | $882.00 10-Q · filed 2018-05-21 | |||||||||
| 2016-12-31 | $23.77K 10-K · filed 2018-04-16 | |||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $0.00 derived: sum of 2 quarters · filed 2017-09-25 | $0.00 derived: sum of 3 quarters · filed 2017-09-25 | $1.40K 10-K · filed 2017-09-25 | ||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $0.00 derived: sum of 2 quarters · filed 2017-09-08 | $1.40K 10-Q · filed 2017-09-08 | -$13.31K derived: sum of 4 quarters · filed 2017-09-08 | ||||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $1.40K 10-Q · filed 2017-08-30 | -$13.31K derived: sum of 3 quarters · filed 2017-08-30 | -$3.37K derived: sum of 4 quarters · filed 2017-08-30 | ||||||
| 2015-03-31 | $1.40K 10-Q · filed 2017-08-07 | -$13.31K derived: sum of 2 quarters · filed 2017-08-07 | -$3.37K derived: sum of 3 quarters · filed 2017-08-07 | -$1.37K derived: sum of 4 quarters · filed 2017-08-07 | ||||||
| 2014-12-31 | -$14.71K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | -$4.76K derived: sum of 2 quarters · filed 2017-06-19 | -$2.77K derived: sum of 3 quarters · filed 2017-06-19 | $11.01K 10-K · filed 2017-06-19 | $48.30K 10-K · filed 2015-04-14 | |||||
| 2014-09-30 | $9.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $11.95K derived: sum of 2 quarters · filed 2015-12-01 | $25.72K 10-Q · filed 2015-12-01 | $25.72K derived: sum of 4 quarters · filed 2015-12-01 | ||||||
| 2014-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $15.77K 10-Q · filed 2015-08-19 | $15.77K derived: sum of 3 quarters · filed 2015-08-19 | $36.11K derived: sum of 4 quarters · filed 2015-08-19 | ||||||
| 2014-03-31 | $13.77K 10-Q · filed 2015-05-15 | $13.77K derived: sum of 2 quarters · filed 2015-05-15 | $34.11K derived: sum of 3 quarters · filed 2015-05-15 | $35.17K derived: sum of 4 quarters · filed 2015-05-15 | $379.20K 10-Q · filed 2014-05-14 | |||||
| 2013-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $20.34K derived: sum of 2 quarters · filed 2015-04-14 | $21.40K derived: sum of 3 quarters · filed 2015-04-14 | $27.67K 10-K · filed 2015-04-14 | $365.43K 10-K · filed 2014-03-27 | |||||
| 2013-09-30 | $20.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $21.40K derived: sum of 2 quarters · filed 2014-11-13 | $27.67K 10-Q · filed 2014-11-13 | $111.18K 10-Q · filed 2013-11-08 | $42.05K derived: sum of 4 quarters · filed 2014-11-13 | $448.94K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $1.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | $7.33K 10-Q · filed 2014-08-19 | $21.71K derived: sum of 3 quarters · filed 2014-08-19 | $265.98K derived: sum of 4 quarters · filed 2014-08-19 | $345.09K 10-Q/A · filed 2013-09-06 | |||||
| 2013-03-31 | $6.28K 10-Q · filed 2014-05-14 | $20.65K derived: sum of 2 quarters · filed 2014-05-14 | $264.93K derived: sum of 3 quarters · filed 2014-05-14 | |||||||
| 2012-12-31 | $14.38K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $258.65K derived: sum of 2 quarters · filed 2014-03-27 | $334.34K 10-K · filed 2014-03-27 | |||||||
| 2012-09-30 | $244.27K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | $319.96K 10-Q · filed 2013-11-08 | ||||||||
| 2012-06-30 | $75.69K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |